首页> 外文期刊>Journal of the Brazilian Chemical Society >Simultaneous determination of rifampicin and isoniazid in urine and pharmaceutical formulations by multivariate visible spectrophotometry
【24h】

Simultaneous determination of rifampicin and isoniazid in urine and pharmaceutical formulations by multivariate visible spectrophotometry

机译:多元可见分光光度法同时测定尿液和药物制剂中的利福平和异烟肼

获取原文
获取原文并翻译 | 示例
           

摘要

Partial least squares regression (PLSR) was used for the simultaneous quantification of rifampicin (RIF) and isoniazid (INH) by visible spectrophotometry using a simple derivatization reaction. In the presence of neocuproine, copper(II) is easily reduced by INH to a Cu(I)-neocuproine complex that shows an absorption maximum at 455 nm. Under these conditions, RIF shows an absorption maximum at 449 nm. The calibration set was established between 8 and 57 mg L~(-1) for RIF and 1.5 and 7 mg L~(-1) for INH. The method was applied to the determination of the drugs in urine samples (recoveries between 92 and 119%) and in pharmaceutical formulations (relative error lower than 5%).
机译:偏最小二乘回归(PLSR)用于使用简单的衍生化反应通过可见分光光度法同时定量利福平(RIF)和异烟肼(INH)。在新环丙氨酸的存在下,INH容易将铜(II)还原为在455 nm处显示最大吸收的Cu(I)-新古铜络合物。在这些条件下,RIF在449 nm处显示最大吸收。 RIF的校正设定为8至57 mg L〜(-1),INH的校正设定为1.5至7 mg L〜(-1)。该方法用于测定尿液样品(回收率在92%至119%之间)和药物制剂中的药物(相对误差低于5%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号